Here are a set of high quality e-learning courses that are provided by The Global Health Network. These are short courses designed to support the design and operation of clinical and laboratory studies and in the capture of high quality and ethical data. These are general research skills courses that apply to all types of study.
All of these courses are free to take, and each can be taken offline if needed, with the quiz being the only part that requires internet access. To view other eLearning courses please visit The Global Health Training Centre. All eLearning coures offer certificates for those who score over 80% in the final quiz.
We aim to provide these courses in multiple languages, and many translations are in progress. However, if you know someone who might be able to help by volunteering their time in translating these courses, please let us know! In the meanwhile, the google translate function is also available at the top of the screen as an interim means of assistance.
The REDe team is also currently working on a gap analysis using the Delphi method to determine the most pressing gaps in training that exist in the regions covered by the EU Zika Consortia, so as to target specific training gaps. REDe's regional centres of excellence will then work together to deliver free skills training for research staff, as well as offering blended learning (in-person support to those taking eLearning courses).
The Global Health Network e-Learning courses are of high quality and recognised by organisations such as TDR, DNDi, IAVI, AERAS etc. The Global Health Network has established a recognition scheme where various well respected organisations and institutions state their endorsement and recognition of these courses. This recognition scheme is an alternative to accreditation. This approach is more appropriate because any form of accreditation would be bound to the authority of an individual organisation from a single country/region. This contradicts the ethos of The Global Health Network as an open access collaboration to support clinical trials in all regions and for all disease areas.